Compare MSGE & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSGE | SRPT |
|---|---|---|
| Founded | 2020 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.3B |
| IPO Year | N/A | 1997 |
| Metric | MSGE | SRPT |
|---|---|---|
| Price | $53.22 | $22.22 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 29 |
| Target Price | ★ $52.20 | $26.23 |
| AVG Volume (30 Days) | 321.7K | ★ 3.7M |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | $962,282,000.00 | ★ $2,413,715,000.00 |
| Revenue This Year | $9.36 | $13.83 |
| Revenue Next Year | $5.33 | N/A |
| P/E Ratio | $73.55 | ★ N/A |
| Revenue Growth | 0.68 | ★ 47.15 |
| 52 Week Low | $28.29 | $10.42 |
| 52 Week High | $53.62 | $131.31 |
| Indicator | MSGE | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 71.11 | 58.09 |
| Support Level | $48.66 | $21.44 |
| Resistance Level | $51.22 | $23.00 |
| Average True Range (ATR) | 1.50 | 1.31 |
| MACD | 0.37 | 0.48 |
| Stochastic Oscillator | 92.40 | 87.39 |
Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.